# Spark Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spark-therapeutics

- Industry: Biotechnology
- Headquarters: Philadelphia, US
- Website: www.sparktx.com
- Total disclosed funding: $73M
- Latest round: Series B (May 27, 2014)
- Investors on record: 7

## About

Established in 2013 and based in Pennsylvania, US, Spark Therapeutics, Inc. operates as a developer of a gene therapy platform that helps in discovering treatments for genetic diseases. The company uses adeno-associated viral (AAV) vectors for investigational research.

## Funding rounds

- Series B, May 27, 2014, $73M — Sofinnova Investments, T Rowe Price, Wellington Management, Rock Springs Capital, Brookside Capital, Deerfield Partners, The Children's Hospital of Philadelphia

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series B
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series B
- Rock Springs Capital — Series B
- Brookside Capital — Series B
- Deerfield Partners — Series B
- The Children's Hospital of Philadelphia — Series B